ST. CHARLES, MO. — On Jan. 16, Royal Canin North America launched its new dog food line SKINTOPIC™ that can help manage canine atopic dermatitis. The line promotes a strong skin barrier and immunity to support sensitive skin.
Canine atopic dermatitis is a chronic skin disease in which dogs are highly sensitive to environmental allergens. According to research shared by Royal Canin, one in every 10 dogs is impacted by the skin disease. A clinical trial showed that nutrition can help reduce itch, as well as medication reliance, caused by atopic dermatitis, according to the pet food company.
“Royal Canin is committed to making a better world for pets by putting the needs of pets at the forefront of scientific innovation,” said Jean-Lin Pelatan, general manager of Royal Canin’s US Veterinary business unit. “We are proud to introduce SKINTOPIC, a nutritional solution for the management of atopic dermatitis, backed by robust science. We are confident this unique diet will help veterinarians provide better outcomes in atopy management.”
The new diet is formulated with DERMAUXILIUM, a patented blend of nutrients and antioxidants that promote skin and coat health. According to a study conducted by the University of Zurich, 82% of dogs fed SKINTOPIC for nine months required less medication and 64% experienced less itch.
Royal Canin’s SKINTOPIC dog food line will be available in June 2023.
Read more about new pet food and treat products.